226 related articles for article (PubMed ID: 7503813)
41. Inhibition of the transcriptional function of p53 by EWS-Fli1 chimeric protein in Ewing Family Tumors.
Li Y; Tanaka K; Fan X; Nakatani F; Li X; Nakamura T; Takasaki M; Yamamoto S; Iwamoto Y
Cancer Lett; 2010 Aug; 294(1):57-65. PubMed ID: 20153576
[TBL] [Abstract][Full Text] [Related]
42. SRE elements are binding sites for the fusion protein EWS-FLI-1.
Magnaghi-Jaulin L; Masutani H; Robin P; Lipinski M; Harel-Bellan A
Nucleic Acids Res; 1996 Mar; 24(6):1052-8. PubMed ID: 8604338
[TBL] [Abstract][Full Text] [Related]
43. The EWS protein is dispensable for Ewing tumor growth.
Kovar H; Jug G; Hattinger C; Spahn L; Aryee DN; Ambros PF; Zoubek A; Gadner H
Cancer Res; 2001 Aug; 61(16):5992-7. PubMed ID: 11507040
[TBL] [Abstract][Full Text] [Related]
44. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma.
Bailly RA; Bosselut R; Zucman J; Cormier F; Delattre O; Roussel M; Thomas G; Ghysdael J
Mol Cell Biol; 1994 May; 14(5):3230-41. PubMed ID: 8164678
[TBL] [Abstract][Full Text] [Related]
45. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1.
May WA; Lessnick SL; Braun BS; Klemsz M; Lewis BC; Lunsford LB; Hromas R; Denny CT
Mol Cell Biol; 1993 Dec; 13(12):7393-8. PubMed ID: 8246959
[TBL] [Abstract][Full Text] [Related]
46. Identification of Ewing's sarcoma protein as a G-quadruplex DNA- and RNA-binding protein.
Takahama K; Kino K; Arai S; Kurokawa R; Oyoshi T
FEBS J; 2011 Apr; 278(6):988-98. PubMed ID: 21244633
[TBL] [Abstract][Full Text] [Related]
47. The role of Fli-1 in normal cell function and malignant transformation.
Truong AH; Ben-David Y
Oncogene; 2000 Dec; 19(55):6482-9. PubMed ID: 11175364
[TBL] [Abstract][Full Text] [Related]
48. Biology of EWS/FLI and related fusion genes in Ewing's sarcoma and primitive neuroectodermal tumor.
May WA; Denny CT
Curr Top Microbiol Immunol; 1997; 220():143-50. PubMed ID: 9103680
[No Abstract] [Full Text] [Related]
49. Transformation induced by Ewing's sarcoma associated EWS/FLI-1 is suppressed by KRAB/FLI-1.
Chan D; Wilson TJ; Xu D; Cowdery HE; Sanij E; Hertzog PJ; Kola I
Br J Cancer; 2003 Jan; 88(1):137-45. PubMed ID: 12556973
[TBL] [Abstract][Full Text] [Related]
50. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours.
Delattre O; Zucman J; Plougastel B; Desmaze C; Melot T; Peter M; Kovar H; Joubert I; de Jong P; Rouleau G
Nature; 1992 Sep; 359(6391):162-5. PubMed ID: 1522903
[TBL] [Abstract][Full Text] [Related]
51. Ewing's sarcoma fusion protein, EWS/Fli-1 and Fli-1 protein induce PLD2 but not PLD1 gene expression by binding to an ETS domain of 5' promoter.
Kikuchi R; Murakami M; Sobue S; Iwasaki T; Hagiwara K; Takagi A; Kojima T; Asano H; Suzuki M; Banno Y; Nozawa Y; Murate T
Oncogene; 2007 Mar; 26(12):1802-10. PubMed ID: 16964281
[TBL] [Abstract][Full Text] [Related]
52. EWS-FLI-1 and EWS-ERG chimeric mRNAs in Ewing's sarcoma and primitive neuroectodermal tumor.
Ida K; Kobayashi S; Taki T; Hanada R; Bessho F; Yamamori S; Sugimoto T; Ohki M; Hayashi Y
Int J Cancer; 1995 Nov; 63(4):500-4. PubMed ID: 7591257
[TBL] [Abstract][Full Text] [Related]
53. Identification of target genes for the Ewing's sarcoma EWS/FLI fusion protein by representational difference analysis.
Braun BS; Frieden R; Lessnick SL; May WA; Denny CT
Mol Cell Biol; 1995 Aug; 15(8):4623-30. PubMed ID: 7623854
[TBL] [Abstract][Full Text] [Related]
54. An EWS/ERG fusion with a truncated N-terminal domain of EWS in a Ewing's tumor.
Peter M; Mugneret F; Aurias A; Thomas G; Magdelenat H; Delattre O
Int J Cancer; 1996 Jul; 67(3):339-42. PubMed ID: 8707406
[TBL] [Abstract][Full Text] [Related]
55. EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations.
Giovannini M; Biegel JA; Serra M; Wang JY; Wei YH; Nycum L; Emanuel BS; Evans GA
J Clin Invest; 1994 Aug; 94(2):489-96. PubMed ID: 8040301
[TBL] [Abstract][Full Text] [Related]
56. The FLI-1 and chimeric EWS-FLI-1 oncoproteins display similar DNA binding specificities.
Mao X; Miesfeldt S; Yang H; Leiden JM; Thompson CB
J Biol Chem; 1994 Jul; 269(27):18216-22. PubMed ID: 7517940
[TBL] [Abstract][Full Text] [Related]
57. In situ reverse-transcriptase polymerase chain reaction demonstration of the EWS/FLI-1 fusion transcript in Ewing's sarcomas and peripheral primitive neuroectodermal tumors.
Krams M; Peters J; Boeckel F; Raether A; Ambros PF; Parwaresch R; Harms D
Virchows Arch; 2000 Sep; 437(3):234-40. PubMed ID: 11037342
[TBL] [Abstract][Full Text] [Related]
58. Interference with the constitutive activation of ERK1 and ERK2 impairs EWS/FLI-1-dependent transformation.
Silvany RE; Eliazer S; Wolff NC; Ilaria RL
Oncogene; 2000 Sep; 19(39):4523-30. PubMed ID: 11002425
[TBL] [Abstract][Full Text] [Related]
59. EWS/ETS proteins promote expression and regulate function of the homeodomain transcription factor BRN3A.
Gascoyne DM; Dunne J; Behjati S; Sebire NJ; Anderson J; Latchman DS
Oncogene; 2010 May; 29(21):3134-45. PubMed ID: 20348952
[TBL] [Abstract][Full Text] [Related]
60. EWS-FLI1 fusion transcripts identified in patients with typical neuroblastoma.
Burchill SA; Wheeldon J; Cullinane C; Lewis IJ
Eur J Cancer; 1997 Feb; 33(2):239-43. PubMed ID: 9135495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
